Financial Performance & Capital Allocation - The company's Q1 2025 LTM Adjusted EBITDA was $2469 million[137] - The company's Q1 2025 LTM Free Cash Flow was $1567 million[137] - The company's Q1 2025 LTM FCF/Adj EBITDA conversion was 63%[137] - From 2017 to Q1 2025, the company returned $5880 million to shareholders[139] - The company has share repurchase authorizations through 2029[40] Competitive Advantages & Market Position - The company is the world's largest ammonia producer[102] - North America has long-term sustainable structural advantages, including access to low-cost natural gas and import-dependent, highly productive agriculture[50, 51] - The company's North American production network has approximately 20 million product tons of annual capacity[57] - Net importers require approximately 55 million metric tons of urea annually[70] Growth Initiatives & Decarbonization - The company is investing in the Blue Point JV, with an estimated CF contribution of approximately $2 billion[40, 127] - The company targets a 37% reduction in Scope 1 CO2 intensity[113] - Decarbonization efforts are projected to provide approximately $200 million in EBITDA annually[166]

Established 1913 June 24, 2025 Acquisition of Forward-Looking Statements This presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about Glacier Bancorp, Inc. ("the Company")'s plans, objectives, expectations and intentions that are not historical facts, and other statements identified by words such as "expects," "anticipates," "intends," "plans," "believes, ...

Pipeline Highlights - XPro: Phase 2 Alzheimer's trial fully enrolled with top-line cognition results expected in June 2025[5], Phase I data showed a 222% increase in Contactin-2 and a 56% decrease in Neurogranin after 12 weeks of treatment[23] - CORDStrom: Completed blinded randomized trial in Recessive Dystrophic Epidermolysis Bullosa (RDEB) with US BLA submission planned for 2026[5], targeting a > $1 billion peak sales opportunity in the US, UK, and EU[50] - INKmune: Phase I dose escalation cohorts complete, with ongoing Phase 2 Metastatic Castrate Resistant Prostate Cancer (mCRPC) data readouts in 2025[5] XPro (Alzheimer's Disease) - TNF inhibitors reduce the risk of developing AD by 60% based on epidemiological studies of over 60 million cases[15] - Phase I results showed dose-dependent reduction of CSF biomarkers of neuroinflammation in AD patients[16] CORDStrom (RDEB) - CORDStrom is potentially the first systemic therapy for RDEB, with itch benefit as a key differentiating factor[50] - Mission EB trial: 30 pediatric patients with RDEB were treated in a double-blind, randomized, placebo-controlled cross-over design clinical trial[52, 56] INKmune (Cancer) - INKmune converts resting NK cells to cancer-killing memory-like NK cells[5, 73]

January 2025 ImmunityBio Investor Presentation Forward-Looking Statements and Intended Use This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding data and results from clinical trials and potential implications therefrom, commercialization plans and timelines, including product availability and shipments, potential regulatory pathways and approval requests and submissions, FDA, UK MHRA, EU EMA and other r ...

Forward-Looking Statements and Intended Use This presentation and the accompanying verbal remarks contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding data and results from clinical trials and potential implications therefrom, commercialization plans and timelines, including product availability and shipments, potential regulatory pathways and approval requests and submissions, FDA and other regulatory agency meetings, ti ...

Company Overview - As of March 31, 2025, Carl Icahn and his affiliates owned approximately 86% of IEP's outstanding depositary units[7,8] - As of May 15, 2025, IEP has a $200 annualized distribution, which is a 207% yield[7] - As of March 31, 2025, IEP has liquidity through its investment in the Investment Funds of approximately $25 billion[7] Financial Performance (LTM March 31, 2025) - Investment segment assets were $3850 million, with a net loss attributable to IEP of $333 million[7] - Energy segment assets were $4722 million, with net sales of $7393 million and a net loss attributable to IEP of $153 million[7] - Automotive segment assets were $1881 million, with net sales of $1470 million and a net loss attributable to IEP of $34 million[7] - Food Packaging segment assets were $434 million, with net sales of $397 million and a net loss attributable to IEP of $20 million[7] - Real Estate segment assets were $512 million, with net sales of $95 million and a net loss attributable to IEP of $6 million[7] - Home Fashion segment assets were $220 million, with net sales of $181 million and a net loss attributable to IEP of $9 million[7] - Pharma segment assets were $274 million, with net sales of $107 million and a net income attributable to IEP of $6 million[7]

INVESTOR PRESENTATION Investor Relations Sean Rourke (860) 263-4709 sean.rourke@virtus.com June 2024 IMPORTANT DISCLOSURES This presentation contains statements that are, or may be considered to be, forward-looking statements. All statements that are not historical facts, including statements about our beliefs or expectations, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may be identified by such forward-looking ter ...

Financial Performance & Guidance - Lakeland's LTM (Last Twelve Months) Revenue is $1776 million[11] and LTM Adjusted EBITDA excluding FX is $141 million[11] - Q1 2026 revenue increased by 29% to $467 million compared to $363 million in Q1 2025[49, 68] - The company anticipates FY26 revenue between $210 million and $220 million, and Adjusted EBITDA excluding FX between $24 million and $29 million[50, 68] - Q1 2026 Adjusted EBITDA excluding FX was $06 million, a significant decrease from $38 million in Q1 2025[49] Acquisitions & Strategy - Lakeland has been actively expanding through acquisitions, including Veridian Limited, LHD Group, Jolly Scarpe, and Pacific Helmets[12] - The company aims to solidify its position as a full-service vendor for head-to-toe safety apparel and services through strategic priorities like M&A and product line extensions[30] - Lakeland is focused on building a premier global fire brand by investing in high-growth geographies and optimizing operations[30] Market & Competitive Position - The total addressable market for industrial safety is approximately $11 billion with a mid-to-high-single-digit growth rate[27] - Lakeland emphasizes its competitive advantages, including a company-owned global manufacturing base, a diversified product portfolio, and fast delivery lead times[32, 33, 34] Financial Position - As of April 30, 2025, Lakeland has $186 million in cash and $247 million in debt[11] - Lakeland closed a Public Offering of 2,093,000 shares of its common stock for net proceeds of approximately $428 million on January 24, 2025[12]

Q2 2025 Performance - Housing revenues decreased by 10% year-over-year, totaling $1.53 billion in Q2 2025 compared to $1.70 billion in Q2 2024[21] - Deliveries decreased by 11% year-over-year, with 3,120 homes delivered in Q2 2025 versus 3,523 in Q2 2024[21] - Net orders decreased by 13% year-over-year, from 3,997 in Q2 2024 to 3,460 in Q2 2025[21] - Net order value decreased by 21% year-over-year, amounting to $1.61 billion in Q2 2025 compared to $2.03 billion in Q2 2024[21] - Backlog homes decreased by 24% year-over-year, from 6,270 in Q2 2024 to 4,776 in Q2 2025[21] - Backlog value decreased by 27% year-over-year, totaling $2.29 billion in Q2 2025 compared to $3.12 billion in Q2 2024[21] Financial Highlights - Total liquidity was $1.19 billion, including $308.9 million in cash and $881.7 million of available capacity under the unsecured revolving credit facility[22] - The company repurchased approximately 3.7 million shares of its outstanding common stock at a total cost of $200 million during the quarter[22] - Stockholders' equity totaled $3.99 billion, and book value per share increased 10% to $58.64[22] Strategic Positioning - Approximately 60% to 70% of the company's business is Built to Order (BTO), allowing buyers to personalize their homes[3] - The company's ENERGY STAR homes are up to 20% more efficient than standard new homes built to code[91]

Financial Performance - Net Revenue for 12M25 reached approximately BRL 7,199 million, a 4% increase compared to BRL 6,922 million in 12M24[5] - Adjusted EBITDA for 12M25 was approximately BRL 3,445 million, a 12.2% increase compared to BRL 3,070 million in 12M24[5] - Adjusted EBITDA Margin for 12M25 was 47.9%, a 3.5 percentage point increase compared to 44.4% in 12M24[5] - Net Income decreased by 62.3%, from BRL 1,476 million in 12M24 to BRL 557 million in 12M25[5] Production and Sales - TRS (Total Recoverable Sugar) Sold reached 3,353 thousand tons in 12M25, a decrease of 2% compared to 3,423 thousand tons in 12M24[5] - Sugar production costs for Own Cane were BRL 2,533 per ton[16] - For the 25/26 Harvest, 699 thousand tons of sugar are hedged at an average price of USD 19.60 c/p[18] Indebtedness - Gross Debt increased by 23.8%, from BRL 6,537 million in Mar/24 to BRL 8,089 million in Mar/25[28] - Net Debt increased by 48.6%, from BRL 3,315 million in Mar/24 to BRL 4,926 million in Mar/25[28] - Net Debt / LTM EBITDA ratio increased from 1.08x in Mar/24 to 1.43x in Mar/25[28] Guidance - The company expects a 1.8% increase in TRS Produced for 12M26, reaching 3,539 thousand tons[31] - Crushed Sugarcane is projected to be 22,600 thousand tons for 12M26, a 3.7% increase[31] - Total Capex for 12M26 is guided at BRL 2,316 million, a 15.3% decrease[34, 35]